Rosalind Advisors reported a 9.8% stake in Fennec Pharmaceuticals FENC · 2,746,840 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 9.8%
Last report: 7.5% · filed 25/11/13
Shares held: 2,746,840 sh
Class: Common Shares
Stock: Fennec Pharmaceuticals FENC
Holder: Rosalind Advisors
Event date: 25/12/31
Filed: 26/02/11

9.8% stake · +2.3pp from the last report

Stake: 9.8%
Last report: 7.5%
Since last report: +2.3pp

Fennec Pharmaceuticals trades, last 26 weeks

What else happened in Fennec Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Rosalind Advisors's other 5% stake reports

Rosalind Advisors
5% stakeFemasys
5% stake
Femasys
FEMY
9.9% stake
4,687,500 sh
9.9% stake
Filed 08/14
Rosalind Advisors
5% stakeRegentis Biomaterials
5% stake
Regentis Biomaterials
RGNT
9.9% stake
1,428,570 sh
9.9% stake
Filed 08/13
Rosalind Advisors
5% stakeFennec Pharmaceuticals
5% stake
Fennec Pharmaceuticals
FENC
8.8% stake
3,041,533 sh
8.8% stake
Filed 05/14
Rosalind Advisors
5% stakeCellectar Biosciences
5% stake
Cellectar Biosciences
CLRB
5.5% stake
247,715 sh
5.5% stake
Filed 02/10
Rosalind Advisors
5% stakeDelcath Systems
5% stake
Delcath Systems
DCTH
9.9% stake
6,719,993 sh
9.9% stake
Filed 02/10